News
Sanofi doubles down on its Orano Med partnership on radioligand therapies for cancer, taking a €300m stake in the company. Skip to main content Tuesday 24 June 2025 . BlueSky linkedin youtube ...
Prilenia Therapeutics is planning to file its Huntington’s disease drug pridopidine in the EU shortly, after mixed results in a phase 3 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback